Phacilitate

What Phacilitate does

Phacilitate operates a global events and content platform serving the advanced therapies (cell and gene therapy) industry, founded in 2001 and headquartered in London as a wholly-owned brand within Clarion Events Limited. Its core products are three flagship annual conferences—Advanced Therapies Europe (Barcelona), Advanced Therapies World (Riyadh), and Advanced Therapies Week (San Diego)—which together serve as the primary convening points for therapeutic developers, investors, regulators, CDMOs/CROs, academics, and patient-focused organizations across more than 160 countries. Over 24 years the company has aggregated a community of 66,000+ members, including 23,000+ tools/technology/service providers and 18,000+ therapeutic developers, and describes its events as award-winning within the sector.

The underlying platform combines event management software (a Partnering App), a Networking Concierge for curated introductions, the Cell and Gene Directory (a persistent digital listing service), Phacilitate.TV (a webinar/video library), and supplementary programs including the Innovation Exchange startup pitch platform, the Investment Summit, and the Women in Advanced Therapies (WIAT) Congress. Technology is positioned as 'technology-enabled' and curated rather than AI-driven, with the differentiation resting on community depth, brand longevity, and the in-person networking ritual rather than on proprietary software IP. Distribution is anchored by the three regional event franchises on a fixed annual calendar supplemented by year-round digital content and an email/newsletter channel.

Phacilitate monetizes through a mix of one-time and recurring streams: ticket and pass sales (Standard, VIP, Startup tiers) for each flagship event; sponsorship and exhibition packages (golden sponsorships, session/workshop sponsors, exhibition stands); and recurring digital revenue from Phacilitate.TV sponsorships, webinar sponsorships, and post-event content access subscriptions. Pricing is quote-based and not publicly disclosed. The customer base is diversified across named enterprise accounts (Corning Life Sciences, Cryoport, Catalent), biotech startups, academic medical centers, and sector accelerators, with Biocat and Cell and Gene Therapy Catapult serving as core strategic partners for programming.

Name

Phacilitate

Legal name

Clarion Events Limited

Website

https://phacilitate.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Phacilitate is a UK-based events and content platform serving the global cell and gene therapy industry through three flagship annual conferences—Advanced Therapies Europe, World, and Week—complemented by the Cell and Gene Directory, Phacilitate.TV, and curated networking services for biotech developers, investors, regulators, and CDMOs.

Ownership category

akta.pro rank

Product category

Biotech / Advanced Therapies Industry Conferences and Events

NAICS

Convention and Trade Show Organizers (561920), Business Associations (813910), Educational Support Services (61171)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Medical & Health Sciences Congresses (THAHAJAA)

akta.pro secondary industries

Health, Wellness & Fitness Expos (MPAGAFAF), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Biotech industry conferences
• Cell therapy events
• Gene therapy networking
• Advanced therapies summits
• Life sciences B2B events

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Marketing or Sales, Personnel, Infrastructure, Technology or R&D, Others

Revenue model

1. Event Tickets and Passes: Revenue from selling attendance tickets and various pass types (VIP passes, standard passes) to the Advanced Therapies Europe, World, and Week conferences. Pricing varies by pass type and tier.
2. Sponsorship and Exhibition: Revenue from companies sponsoring sessions, booking exhibition stands, and various sponsorship packages at events. Includes golden sponsorships, session sponsorships, and partnership opportunities.
3. Digital Opportunities: Digital sponsorship and marketing opportunities including webinar sponsorships, Phacilitate.TV content placement, and digital advertising across the platform.
4. Conference Content Access: Post-event content access for registered attendees, including presentation recordings and materials.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Phacilitate is a B2B events and content platform serving the global advanced therapies (cell and gene therapy) industry. Its core offering is three flagship annual conferences — Advanced Therapies Europe (Barcelona), Advanced Therapies World (Riyadh), and Advanced Therapies Week (San Diego) — that combine curated networking, expert-led programming, and deal-making sessions to connect therapeutic developers, investors, regulators, manufacturers, and service providers. Surrounding these events are year-round products including a curated Networking Concierge/Partnering App, an on-demand Webinar Library (Phacilitate.TV), the Cell and Gene Directory, the Innovation Exchange startup pitch platform, the Investment Summit investor track, and the Women in Advanced Therapies (WIAT) Congress leadership program.

Product overview

Phacilitate is an events and content platform serving the advanced therapies industry. The core offering consists of three major annual conferences—Advanced Therapies Europe, Advanced Therapies World, and Advanced Therapies Week—that serve as the primary platforms for networking, deal-making, and knowledge exchange across the cell and gene therapy ecosystem. These events are complemented by specialized programs including the Innovation Exchange (startup pitch competition), Investment Summit (investor-focused track), Women in Advanced Therapies Congress (leadership program), and Networking Concierge (curated introduction service). The company also provides digital content through its Webinar Library and maintains the Cell and Gene Directory for industry connections. The platform supports biotech companies at every stage of commercialization—from early science through commercial scale—connecting therapeutic developers with investors, regulators, manufacturers, and service providers.

Differentiator

Problem solved

Functional benefit

Brands

• Advanced Therapies Week: Annual flagship event held in San Diego, USA connecting the global advanced therapies community
• Advanced Therapies Europe
• Advanced Therapies World
• Phacilitate.TV
• WIAT Congress
• Investment Summit
• Innovation Exchange
• Cell and Gene Directory

Products and services

• Advanced Therapies Europe Europe's leading annual advanced therapies conference held in Barcelona, covering cell and gene therapy development, manufacturing, investment, and commercialization across the full ecosystem. Targeted at therapeutic developers, investors, regulators, manufacturers, and service providers in the European advanced-therapy market.
• Advanced Therapies World Global advanced therapies conference focused on international market expansion, held in Riyadh, Saudi Arabia, connecting APAC, US, Europe, and Middle East ecosystems in cell and gene therapy. Targeted at therapeutic developers, investors, and service providers pursuing Middle East and cross-regional partnerships.
• Advanced Therapies Week Flagship multi-day advanced therapies conference held annually in San Diego, featuring deal-making, investment summits, and comprehensive programming across cell and gene therapy themes. Targeted at therapeutic developers, investors, regulators, manufacturers, and service providers across the US and global ecosystem.
• Webinar Library On-demand digital library of webinar recordings covering advanced therapies topics including clinical development, manufacturing, regulation, investment, and emerging technologies. Accessible to registered attendees and broader community for year-round engagement with Phacilitate content.
• Innovation Exchange Competition platform where innovative biotech startups pitch their ideas to expert investors with real-time feedback, supporting early-stage company visibility and funding opportunities within Phacilitate's Europe flagship event. Targeted at emerging biotech founders seeking investor connections.
• Investment Summit Focused investment track connecting therapeutic developers with venture capital and investors, featuring deal-focused sessions, funding panels, and alternative capital structure discussions. Embedded within Advanced Therapies Europe for investors and biotechs in the advanced-therapy space.
• Women in Advanced Therapies (WIAT) Congress Dedicated congress addressing career development, leadership progression, and gender diversity in the advanced therapies industry, featuring roundtables, workshops, and networking for women in the field. Embedded as part of Advanced Therapies Europe programming.
• Networking Concierge Technology-enabled facilitated networking service that uses curated introductions to help attendees connect with the most relevant people for their professional goals at Phacilitate events. Targeted at delegates seeking high-value, goal-driven meetings rather than ad-hoc networking.
• Cell and Gene Directory Online directory connecting advanced therapies professionals with solution providers, manufacturers, and service companies across the cell and gene therapy ecosystem, used for partner discovery and business development year-round.

Quantifiable outcome

• 66000+ community members
• +4 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Clarion Events LimitedcoreOthersPhacilitate is a part of Clarion Events Limited, a global events and exhibition company. This is a parent-subsidiary relationship providing operational infrastructure and resources for Phacilitate's event operations.
• BiocatcoreStrategic or Co-development PartnerBiocat is a partner organization for Advanced Therapies Europe, hosting the ATMP Day partner event. Biocat is the bioRegion of Catalonia's organization supporting biotechnology and advanced therapies ecosystem development.
• CytivaminorImplementation/ SI/ Consulting PartnerCytiva sponsors workshops at Advanced Therapies Europe, providing technical content on ATMP platform development and manufacturing topics.
• CatalentminorImplementation/ SI/ Consulting PartnerCatalent sponsors workshops at Advanced Therapies Europe, providing expertise on cell therapy manufacturing and commercial operations.
• Cell and Gene Therapy CatapultcoreStrategic or Co-development PartnerCell and Gene Therapy Catapult participates as speakers and advisors at Phacilitate events, contributing to the advanced therapies ecosystem dialogue on UK and global market development.
• Cell and Gene DirectoryminorChannel Partner/ Reseller/ DistributorPhacilitate operates the Cell and Gene Directory platform (cellandgenedirectory.com), a listing service for companies in the advanced therapies ecosystem.
• Dark Horse ConsultingminorImplementation/ SI/ Consulting PartnerDark Horse Consulting sponsors workshops at Advanced Therapies Europe, providing cell and gene therapy expertise and technical content.
• FreseniusminorImplementation/ SI/ Consulting PartnerFresenius partners with Women in Advanced Therapies Congress roundtables at Advanced Therapies Europe, contributing to diversity and culture programming.
• Gift of Life BiologicsminorGTM or Marketing PartnerGift of Life Biologics partners with welcome beach party event at Advanced Therapies Europe in Barcelona.
• AdvanteraminorImplementation/ SI/ Consulting PartnerAdvantera partners with Women in Advanced Therapies roundtables at Advanced Therapies Europe on founding and investment topics.
• CGT CircleminorGTM or Marketing PartnerCGT Circle partners with Women in Advanced Therapies Congress action lab sessions on sponsorship frameworks.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hanson Wade: Specialist B2B events organizer running multiple advanced-therapies and cell/gene therapy conferences. Directly comparable as a niche events company focused on the same therapeutic categories with similar buyer personas.
• Cambridge Healthtech Institute (CHI): Runs numerous life-sciences and bioprocessing conferences including cell therapy tracks. Directly comparable as a specialist events company serving therapeutic developers with technical and commercial programming.
• BIO (Biotechnology Innovation Organization): Operates the BIO International Convention, the largest global biotech partnering event. Directly comparable as a flagship industry conference that brings therapeutic developers, investors, and service providers together for deal-making.
• American Society of Gene & Cell Therapy (ASGCT): Runs the ASGCT Annual Meeting, the leading scientific congress for the gene and cell therapy community. Highly comparable as an advanced-therapies-focused event serving therapeutic developers, researchers, and regulators.

Emerging players

• Alliance for Regenerative Medicine (ARM): Industry association running cell and gene therapy policy, investor, and partnering events. Comparable as a sector-specific community organizer with overlap on advanced-therapy stakeholders and partnering content.

Broad incumbents

• Informa Life Sciences: Major B2B events group operating large life-sciences brands including BioEurope and CPHI. Comparable as a broad incumbent running multiple industry conferences with overlapping biotech/pharma audiences.
• Terrapinn: Global B2B events company running life-sciences shows including Cell & Gene Therapy conferences. Comparable as a broader events incumbent with adjacent offerings in pharma and biotech verticals.
• BioProcess International (BPI) / Informa Connect: Runs bioprocessing and biomanufacturing conferences relevant to cell and gene therapy manufacturing. Comparable as a life-sciences events operator covering overlapping manufacturing and tooling audiences.
• Reuters Events (Pharma): Operator of large pharma industry events including conferences touching advanced therapies and biopharma commercialization. Comparable as a broader events player with adjacent pharma audiences.
• Clarion Events (parent brand portfolio): Phacilitate's parent group runs adjacent life-sciences and pharma events. Comparable as a portfolio operator with overlapping audiences and shared back-office capabilities, and as Phacilitate's corporate parent.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Phacilitate/status/1846928760978694484
• LinkedInlinkedin.com/company/phacilitate-limited

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phacilitate